Fibrogen Stock Price (NASDAQ:FGEN)

Add to My Stocks
$60.1 $2.3 (3.98%) FGEN stock closing price Sep 24, 2018 (Closing)
Prev Close* : $57.8
Market Cap:
$4.87B
Day Low: $56.5
52 Week Low: $40.74
Open: $57.9
Volume: -
Day High: $60.25
52 Week High: $68.55
Dividend:
0.00

Latest Stock Market News

Latest Articles

Fibrogen News - From Partners

FibroGen Reports Second Quarter 2018 Financial Results   by Globe Newswire on Aug 07, 2018

FGEN Stockcharts

View FGEN PE ratio, PS ratio stocks charts and compare with peers.
FGEN Chart
Note: Compare Fibrogen stock price history with the index and industry peers.

Fibrogen Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
34.56
PB ratio (
price to book ratio
)
10.25

Fibrogen Returns

ROE
(return on equity)
-25%

Fibrogen Financial Ratios

Asset Turnover
0.2
Receivables Turnover
11.01
Debt to Equity
0.19
Dividend Yield
0%

FGEN Industry Peers

Company Price Change (%)
Patheon Nv (PTHN)34.980 (0%)
Loxo Oncology (LOXO)163.13.83 (2.4%)
Astrazeneca (AZN)37.850.17 (0.45%)
Astellas Pharma (ALPMY)17.290.01 (0.06%)
Keryx Biopharma (KERX)3.20.05 (1.59%)
Ardelyx (ARDX)4.30.15 (3.61%)
Ptc Therapeutics (PTCT)45.920.78 (1.73%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
AcelRx Pharma (ACRX)4.60.65 (16.46%)
Adamis Pharma (ADMP)3.50.4 (12.9%)
Infinity Pharma (INFI)2.630.23 (9.58%)
Catalyst Pharma (CPRX)3.440.29 (9.21%)
MADRIGAL PHARMA (MDGL)227.1415.76 (7.46%)
Arrowhead Pharma (ARWR)18.70.93 (5.23%)
BioLineRx (BLRX)1.0340.05 (5.1%)
Top gainers from Medical-Drugs industry
* As of Sep 24, 2018
CompanyPriceChange (%)
Spectrum Pharma (SPPI)16.524.84 (22.66%)
Enanta Pharma (ENTA)87.095.32 (5.76%)
Aratana Therapeutics (PETX)5.710.25 (4.19%)
Tesaro Inc (TSRO)36.431.26 (3.34%)
ACER THERAPEUTS (ACER)29.990.95 (3.07%)
AVADEL PHARMA (AVDL)4.280.1 (2.28%)
CTI BioPharma (CTIC)1.950.04 (2.01%)
Top losers from Medical-Drugs industry
* As of Sep 24, 2018

FibroGen Inc Stock News - Partner Headlines

Fibrogen Financial Statements

income statement20172016201520142013
Net Sales or Revenues125.66M179.57M180.82M137.6M102.17M
Net Income-126.2M-61.68M-85.77M-59.5M-14.94M
Total Operating Expense248.27M233.22M258.44M187.69M110.11M
View Fibrogen income statement
balance sheet20172016201520142013
Total Assets898.65M469.55M470.57M483.52M296.95M
Total Liabilities316.2M294.44M273.74M242.85M189.34M
Shareholders Equity582.45M175.1M196.82M240.67M107.6M
View Fibrogen balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities14.34M28.13M30.95M58.1M31.79M
Net Cash from (used by) Operating Activities-66.51M7.1M-18.57M22.41M25.91M
Increase (Decrease) in Prop Plant And Equipment-8.49M-1.25M-1.97M-8.1M-6.8M
View Fibrogen cash flow statement

Fibrogen Stock Message Board

Fibrogen stock price ended the last trading day at $60.1. Looking at Fibrogen market capitalization, which currently stands at $4.87B, we can say that FGEN stock is a Mid Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Fibrogen stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Fibrogen is worth a lot, it will most likely be reflected in an inflated Fibrogen stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 417,708 shares were traded with a closing stock price of $60.1 as of Sep 24, 2018, as can be seen from Fibrogen stock quote. One can view Fibrogen stock chart to follow the stock price trend. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Fibrogen stock dividend was 0.00 during the last quarter. Fibrogen stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.